<DOC>
	<DOCNO>NCT01933282</DOCNO>
	<brief_summary>Study efficacy safety MESA chemotherapy treat NK/T cell lymphoma</brief_summary>
	<brief_title>MESA Treatment NK/T Cell Lymphoma</brief_title>
	<detailed_description>Extranodal natural killer ( NK ) /T-cell lymphoma ( ENKTL ) , nasal type , distinct heterogeneous histopathologic subtype non-Hodgkin lymphoma ( NHL ) , account 5 % ~10 % . The frequency ENKTL among NHL patient significantly high Asia Western country . Despite radiotherapy chemotherapy , prognosis ENKTL patient poor , 5-year median survival time primary nasal site 5 year , non-nasal extranodal sit 6 month . ENKTL aggressive high mortality rate till standard therapy . In recent year SMILE chemotherapy clinical efficacy one first line therapy ENKTL . However apparent regimen extremely toxic grade 4 neutropenia especially Asian patient . On ground , new therapy MESA use Asian patient ENKTL order achieve good efficacy safety .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , T-Cell</mesh_term>
	<mesh_term>Lymphoma , Extranodal NK-T-Cell</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Asparaginase</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Pathological diagnosis NK/T cell lymphoma； At least one objective evaluation ( measurable ) lesion Age 15 ~ 60 year old , men woman limit ECOG ( Eastern Cooperative Oncology Group）performance status 0~3，Expected survive 3 month ; Heart , kidney function normal range Liver function : transminase &lt; 2 time normal value pregnancy test woman childbearing age must negative ; Men woman agree use effective contraception treatment follow year Before test sign write informed consent The early use methotrexate or/and Lasparaginase ; Pregnant nursing , psychiatric patient complicate malignant tumor At time application trial drug , drug contraindication exist research ; Serious infection metabolic diseases Liver dysfunction , serum direct bilirubin , indirect bilirubin , transaminase 2 time high normal ; serum total protein albumin normal ; Renal insufficiency , creatinine clearance rate 2 time higher normal , especially creatinine clearance rate le 30ml/min ; Before enter group , blood : White blood cell &lt; 3×10E9/L ; absolute neutrophil count &lt; 1.5×10E9/L ; platelet &lt; 100×10E9/L ( bone marrow violate ) ; platelet count &lt; 75×10E9/L ( bone marrow invasion ) ; hemoglobin &lt; 100g/L . In 6 month enter group , patient uncontrolled serious cardiovascular disease , include myocardial infarction , IIIIV class heart failure , uncontrolled angina clinically significant pericardial disease , diabetes phlebitis ; HIV antibody positive , HBsAg positive antiviral HBV ( hepatitis B virus ) DNA titer 104copies/ml follow group . HIV antibody positive , HBsAg+ DNA titer 104copies/ml antiviral HBV therapy Coagulation abnormality .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>MESA , chemotherapy , NK/T cell lymphoma</keyword>
</DOC>